Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Knowing when to assess your retirement strategy ensures your financial plan remains effective. Regular evaluations can lead to better outcomes.
21,973 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Warren Buffett's successor, Greg Abel, is drawing new attention as recent 13F filings hint at a shift in Berkshire's ...
A traditional bank flagging a hidden crypto for potential outsized gains sounds unusual. This article breaks down the...
As AI evolves, investors face a choice: a defense-first, multi-year government play or a fast-growing consumer voice ...
A new mega-listing grabbed headlines by raising $26.5 billion, ranking just below SpaceX in U.S. market history. Read...
Nebius has drawn attention with bold AI capacity announcements and aggressive revenue targets. This guide breaks down...
When headlines spotlight a celebrity living abroad, it raises practical questions about how such a move affects money...
Nvidia has stumbled from its record highs in 2026, but a dip can offer opportunity—if you know how to evaluate the od...
Celebrity fashion moments can become financial talking points. This guide explains how to evaluate, insure, and sell ...
Alphabet is now part of the Dow, a milestone that goes beyond a headline. This shift has implications for index desig...
Nvidia surged into the spotlight as a long-term wealth engine for many investors. This guide asks the hard question: ...
Hudbay's 2025 earnings outlook hinges on copper and zinc markets, mine costs, and capital decisions. This guide break...